To Speed CRISPR/Cas9’s Search and Snip, Try Extra Cas9 and gRNA – Genetic Engineering & Biotechnology News
|
To Speed CRISPR/Cas9’s Search and Snip, Try Extra Cas9 and gRNA
Genetic Engineering & Biotechnology News The CRISPR/Cas9 gene-editing system is advantaged by its targeting mechanism’s inherent flexibility, but disadvantaged by this mechanism’s inherent slowness. The mechanism, which depends on a guide RNA (gRNA)-programmable protein, can take a … |
Washington Post |
Cancer-fighting power couple tackles mysteries of the immune system
Washington Post “When it comes to immunotherapy, he is the big boss man.” Few would disagree. In recent years, Allison’s work has ignited a revolution in oncology treatment that frees the immune system to attack malignant tumors. Patients near death have returned to … Advances in cancer treatmentFlorida Today Body’s own immune system can help fight, destroy cancer cellsLexington Herald Leader |
The Advertiser |
Can biohacking cure cancer, or lead to personalised medicines?
The Advertiser “Synthetic biology is actually a horrible name and there were arguments in the early days about it but it just kind of stuck,” he says from the US. “Really, it’s just biology but you can think of synthetic biology as the modern incarnation of genetic … |
R & D Magazine |
Stem Cells Could be Key to Extending Lifespan
R & D Magazine Scientists from the Albert Einstein College of Medicine have discovered that stem cells in the brain’s hypothalamus govern how fast aging occurs in the body, which could result in new strategies for warding off age-related diseases and extending lifespan. |
Endocrinology Advisor |
Peptide Immunotherapy for Type 1 Diabetes: A Promising New Treatment
Endocrinology Advisor Immunomodulatory treatment, or immunotherapy, seeks to influence the immunological pathways that mediate beta cell destruction.1 “In the field of type 1 diabetes, we’ve been actively searching for ways to induce disease remission so that we can limit … |
|
Stem Cell Clinics: More Control Needed?
MedPage Today The FDA is taking measures against unapproved stem cell therapies. (Results from the September 27 poll: almost 80% of responders answered “Yes” to the question, “Are you more likely to chose a T2D drug that also has a label indication for heart disease?”) |
Jacksonville Business Journal |
TapImmune’s new CEO shares the potential of cancer immunotherapies
Jacksonville Business Journal TapImmune (Nasdaq: TPIV) develops cancer-fighting immunotherapies that target breast and ovarian cancers. Immunotherapies that combat cancer are hardly five-years-old, and much of the science behind them was learned in the last decade. Hoang, who … |